GlassScriptPhysician profile
Matthew R Allred
NPI 1194262022
$7,978.81
in general payments reported to CMS, 2019-2025
15 companies · $1,291 in 2025
The $1,291 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,270 · 2022: $3,169 · 2023: $299 · 2024: $1,949 · 2025: $1,291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,153 · Food and Beverage: $1,387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,152.64 |
| Food and Beverage | $1,386.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $6,501.97 | 2021-2025 | Myspine |
| Medtronic, INC. | $481.14 | 2021-2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Boston Scientific Corporation | $274.85 | 2024-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Centinel Spine, LLC | $129.64 | 2021-2022 | |
| Highridge Medical LLC | $126.21 | 2024 | Mobi-C Plug & Fit US |
| Painteq LLC | $92.16 | 2022-2023 | Painteq |
| Mml US, INC. | $83.07 | 2024 | Reactiv8 |
| Vertex Pharmaceuticals Incorporated | $67.76 | 2024-2025 | |
| Spineart USA INC | $45.55 | 2024 | |
| Abbott Laboratories | $41.90 | 2023-2025 | Eterna, Proclaim |
| Ethicon US, LLC | $35.56 | 2022 | |
| Amgen INC. | $32.13 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $31.40 | 2022 | |
| Abbvie INC. | $18.34 | 2023 | |
| Spr Therapeutics, INC | $17.13 | 2025 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Allred listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.